Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Current Deferred Tax Assets: 2011-2012

Historic Current Deferred Tax Assets for Ligand Pharmaceuticals (LGND) over the last 2 years, with Dec 2012 value amounting to $8,000.

  • Ligand Pharmaceuticals' Current Deferred Tax Assets was N/A to $7.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $7.5 million, marking a year-over-year change of. This contributed to the annual value of $8,000 for FY2012, which is 96.62% down from last year.
  • According to the latest figures from FY2012, Ligand Pharmaceuticals' Current Deferred Tax Assets is $8,000, which was down 96.62% from $237,000 recorded in FY2011.
  • In the past 5 years, Ligand Pharmaceuticals' Current Deferred Tax Assets ranged from a high of $237,000 in FY2011 and a low of $8,000 during FY2012.
  • Moreover, its 2-year median value for Current Deferred Tax Assets was $122,500 (2011), whereas its average is $122,500.
  • Data for Ligand Pharmaceuticals' Current Deferred Tax Assets shows a maximum YoY slumped of 96.62% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Ligand Pharmaceuticals' Current Deferred Tax Assets stood at $237,000 in 2011, then plummeted by 96.62% to $8,000 in 2012.